DXI 800
Device
Beckman Coulter, Inc.
Total Payments
$1.9M
Transactions
229
Doctors
76
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $77.12 | 3 | 3 |
| 2023 | $637.06 | 13 | 12 |
| 2022 | $206,670 | 15 | 9 |
| 2021 | $225,754 | 8 | 4 |
| 2020 | $431,379 | 30 | 13 |
| 2019 | $750,687 | 84 | 26 |
| 2018 | $254,759 | 76 | 28 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.8M | 88 | 98.9% |
| Consulting Fee | $10,928 | 11 | 0.6% |
| Travel and Lodging | $4,504 | 22 | 0.2% |
| Food and Beverage | $4,439 | 107 | 0.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,560 | 1 | 0.1% |
Payments by Type
Research
$1.8M
88 transactions
General
$21,431
141 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| BNPNTproBNP | Beckman Coulter, Inc. | $572,981 | 0 |
| hsTnI Trial | Beckman Coulter, Inc. | $460,000 | 0 |
| RACE-IT (hsTnI accelerated protocol prospective trial) | Beckman Coulter, Inc. | $200,000 | 0 |
| BNP/NTproBNP | Beckman Coulter, Inc. | $190,583 | 0 |
| Access AMH Assay as an aid in diagnosis | Beckman Coulter, Inc. | $141,643 | 0 |
| Procalcitonin Study | Beckman Coulter, Inc. | $89,651 | 0 |
| BNP Sample Stability | Beckman Coulter, Inc. | $69,770 | 0 |
| Cardiac Heart Failure Study | Beckman Coulter, Inc. | $40,000 | 0 |
| Cardiac Troponin I Study | Beckman Coulter, Inc. | $28,301 | 0 |
| hsTNI Study | Beckman Coulter, Inc. | $25,937 | 0 |
| Heart failure feasibility study | Beckman Coulter, Inc. | $11,000 | 0 |
| CHF Study | Beckman Coulter, Inc. | $10,500 | 1 |
| hsTNI NRFP Study | Beckman Coulter, Inc. | $4,618 | 0 |
| PHI Testosterone Study | Beckman Coulter, Inc. | $1,380 | 0 |
| Performance of Immunoassay Analyzers | Beckman Coulter, Inc. | $1,169 | 0 |
| Androgen Study | Beckman Coulter, Inc. | $1,000 | 0 |
Ad
Manufacturing Companies
- Beckman Coulter, Inc. $1.9M
Product Information
- Type Device
- Total Payments $1.9M
- Total Doctors 76
- Transactions 229
About DXI 800
DXI 800 is a device associated with $1.9M in payments to 76 healthcare providers, recorded across 229 transactions in the CMS Open Payments database. The primary manufacturer is Beckman Coulter, Inc..
Payment data is available from 2018 to 2024. In 2024, $77.12 was paid across 3 transactions to 3 doctors.
The most common payment nature for DXI 800 is "Unspecified" ($1.8M, 98.9% of total).
DXI 800 is associated with 16 research studies, including "BNPNTproBNP" ($572,981).